Llaguno LR, Corzo CA, Jaramillo VLE

Language: Spanish
References: 26
Page: 47-51
PDF size: 402.02 Kb.

ABSTRACT

Introduction: aging is a universal, heterogeneous, and progressive process that involves multiple changes in individuals and their environment, as well as in the presence of diseases and the way they are addressed. Among geriatric syndromes, sarcopenia is characterized by the loss of muscle mass and strength, including deterioration in physical performance, leading to multiple consequences such as falls, hospitalizations, and premature mortality. The current demographic transition toward an aging population highlights the need for increased awareness, accurate identification, and early management of this condition. Objective: to determine the prevalence of sarcopenia and its associated factors in hospitalized older adults at the Central Military Hospital. Material and methods: patients were randomly selected from multiple inpatient wards of a tertiary care hospital. Men and women aged 60 years and older who met the established inclusion criteria were enrolled. Participants underwent an interview along with assessments to determine muscle strength, muscle mass, and physical performance. Results: a total of 200 patients were included, 112 (56%) women and 88 (44%) men, finding a prevalence of total sarcopenia of 72.5%, with 71.0% being severe and predominantly in females (42.0% for women versus 29.0% for men). Conclusions: sarcopenia is a highly prevalent condition among hospitalized older adults. A clear association between age and severity was observed, with both the prevalence and severity of sarcopenia increasing as age advances.

REFERENCES

1. OMS. World Health Organization. Informe mundial sobre el envejecimiento y la salud. Ginebra: WHO; 2015.

2. Pascual-Fernández J, Fernández-Montero A, Córdova-Martínez A, Pastor D, Martínez-Rodríguez A, Roche E. Sarcopenia: molecular pathways and potential targets for intervention. Int J Mol Sci. 2020; 21 (22): 8844.

3. Rosas-Carrasco O, Manrique-Espinoza B, López-Alvarenga JC, Mena-Montes B, Omaña-Guzmán I. Osteosarcopenia predicts greater risk of functional disability than sarcopenia: a longitudinal analysis of FraDySMex cohort study. J Nutr Health Aging. 2024; 28 (11): 100368.

4. Consejo Nacional de Población. Envejecimiento en México [Internet]. México: CONAPO; s.f. [Consultado el 20 de julio de 2025] Disponible en: https://www.gob.mx/conapo/articulos/envejecimiento-en-mexico?idiom=es

5. Secretaría de Salud. Evaluación, diagnóstico y tratamiento de sarcopenia para población adulta mayor en el primer nivel de atención. México: Secretaría de Salud; 2013.

6. Instituto Nacional de las Personas Adultas Mayores. Proyecciones demográficas de un México que envejece [Internet]. México: INAPAM; s.f. Disponible en: https://www.gob.mx/inapam/articulos/proyecciones-demograficas-de-un-mexico-que-envejece

7. Instituto Nacional de Estadística y Geografía. Esperanza de vida al nacer [Internet]. México: INEGI; s.f. [Consultado el 23 de julio de 2025] Disponible en: https://beta.cuentame.inegi.org.mx/descubre/poblacion/esperanza_de_vida/.

8. Rodríguez-García WD, García-Castañeda L, Vaquero-Barbosa N, Mendoza-Núñez VM, Orea-Tejeda A, Perkisas S et al. Prevalence of dynapenia and presarcopenia related to aging in adult community-dwelling Mexicans using two different cut-off points. Eur Geriatr Med. 2018; 9 (2): 219-225.

9. Espinel-Bermúdez MC, Ramírez-García E, García-Peña C, Salvà A, Ruiz-Arregui L, Cárdenas-Bahena Á, et al. Prevalence of sarcopenia in community-dwelling older people of Mexico City using the EWGSOP diagnostic criteria. JCSM Clin Rep. 2017; 2 (2): 1-9.

10. Salinas-Rodríguez A, Palazuelos-González R, Rivera-Almaraz A, Manrique-Espinoza B. Longitudinal association of sarcopenia and mild cognitive impairment among older Mexican adults. J Cachexia Sarcopenia Muscle. 2021; 12 (6): 1848-1859.

11. Jimenez-Gutierrez GE, Martínez-Gómez LE, Martínez-Armenta C, Pineda C, Martínez-Nava GA, Lopez-Reyes A. Molecular mechanisms of inflammation in sarcopenia: diagnosis and therapeutic update. Cells. 2022; 11 (15): 2359.

12. Montero-Errasquín B, Cruz-Jentoft AJ. Acute sarcopenia. Gerontology. 2023; 69 (5): 519-525.

13. Petermann-Rocha F, Balntzi V, Gray SR, Lara J, Ho FK, Pell JP, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022; 13 (1): 86-99.

14. Welch C, K Hassan-Smith Z, A Greig C, M Lord J, A Jackson T. Acute sarcopenia secondary to hospitalisation - an emerging condition affecting older adults. Aging Dis. 2018; 9 (1): 151-164.

15. Carrillo-Vega MF, Pérez-Zepeda MU, Salinas-Escudero G, García-Peña C, Reyes-Ramírez ED, Espinel-Bermúdez MC, et al. Patterns of muscle-related risk factors for sarcopenia in older Mexican women. Int J Environ Res Public Health. 2022; 19 (16): 10239.

16. Kirk B, Cawthon PM, Arai H, Ávila-Funes JA, Barazzoni R, Bhasin S et al. The conceptual definition of sarcopenia: delphi consensus from the global leadership initiative in sarcopenia (GLIS). Age Ageing. 2024; 53 (3): afae052.

17. Alcocer-Varela J. Guía de instrumentos de evaluación de la capacidad funcional. México: Secretaría de Salud; Instituto Nacional de Geriatría; 2022.

18. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019; 48 (1): 16-31.

19. Zanker J, Sim M, Anderson K, Balogun S, Brennan-Olsen SL, Dent E et al. Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand. J Cachexia Sarcopenia Muscle. 2023; 14 (1): 142-156.

20. Ooi H, Welch C. Obstacles to the early diagnosis and management of sarcopenia: current perspectives. Clin Interv Aging. 2024; 19: 323-332.

21. Cho MR, Lee S, Song SK. A review of sarcopenia pathophysiology, diagnosis, treatment and future direction. J Korean Med Sci. 2022; 37 (18): e146.

22. Sayer AA, Cruz-Jentoft A. Sarcopenia definition, diagnosis and treatment: consensus is growing. Age Ageing. 2022; 51 (10): afac220.

23. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019; 48 (1): 16-31. doi: 10.1093/ageing/afy169. Erratum in: Age Ageing. 2019; 48 (4): 601.

24. Cruz-Jentoft AJ, Landi F, Schneider SM, Zúñiga C, Arai H, Boirie Y et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014; 43 (6): 748-759.

25. Bertschi D, Kiss CM, Beerli N, Kressig RW. Sarcopenia in hospitalized geriatric patients: insights into prevalence and associated parameters using new EWGSOP2 guidelines. Eur J Clin Nutr. 2021; 75 (4): 653-660. doi: 10.1038/s41430-020-00780-7.

26. Espinel-Bermúdez MC, Ramírez-García E, García-Peña C, Salvà A, Ruiz-Arregui L, Cárdenas-Bahena A, Sánchez-García S. Prevalence of sarcopenia in community-dwelling older people of Mexico City using the EGWSOP (European Working Group on Sarcopenia in Older People) diagnostic criteria. JCSM Clinical Reports. 2017; 2 (2): 1-9.